Published 2020-07-20
Andy Zulfiqqar Indrawarman Soeroharjo


Objective: The aim of this article was to reports our experiences PCNL on ADPKD patients. Case(s) Presentation: We report the case of a 38-year-old male with autosomal dominant polycystic kidney disease associated with bilateral staghorn diseases. We performed a supine PCNL on left kidney. Discussion: ADPKD may arise sporadically, the developmental abnormality that resulting in multiple cysts, hypertension, hematuria, polyuria, plank pain, and are prone to reccurent urinary tract infection and renal stones. ADPKD is one most commonly genetics disorder than frequently results in End Stage Renal Disease (ESRD). Population of ADPKD has a higher risk to have a nephrolithiasis, thus it may hastened the onset of ESRD. Open surgeries was one of treatment of choices of ADPKD with staghorn stones, but considering of high rates of morbidity. Recently there’s consistent switching the trend on minimal invasive treatment such as ESWL and PCNL. Conclusion: PCNL may considered as an effective and safe procedure in managing nephrolithiasis in ADPKD, further studies with larger sample and longer periods observation is needed to confirmed role of PCNL in preserving kidney on ADPKD with staghorn kidney.



Supine PCNL, ADPKD, kidney disease


Alam A, Dahl NK, Lipschutz JH, Rossetti S, Smith P, Sapir D, et al. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy. Am J Kidney Dis.2015; 66(4): 564-76.

Idrizi A, Barbullushi M, Gjata M, Koroshi A, Roshi E, Backa T, et al. Prevalence of nephrolithiasis in polycystic kidney disease. 2011; 6(4): 497–501.

Kaygısız O, Coşkun B, Oruç A, Gedik CC, Ersoy A, Kordan Y, et al. Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience. 2018.

Desai M, Baishya R, Dhawan D, Kurien A, Ganpule A, Sabnis R. Management of nephrolithiasis in autosomal dominant polycystic kidney disease-A single center experience. Urol Ann. 2012; 4(1): 29-33.

Horie S, Mochizuki T, Muto S, Hanaoka K, Fukushima Y, Narita I, et al. Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clin Exp Nephrol. 2016; 20(4): 493–509.

Torres VE, Erickson SB, Smith LH, Wilson DM, Hattery RR, Segura JW. The Association of Nephrolithiasis and Autosomal Dominant Polycystic Kidney Disease. Am J Kidney Dis. 1988; 11(4): 318–25.

Barrett BJ, Parfrey PS. Autosomal Dominant Polycystic Kidney Disease and End Stage Renal Disease. Semin Dial. 1991; 4(1): 26–32.

Nishiura JL, Neves RFCA, Eloi SRM, Cintra SMLF, Ajzen SA, Heilberg IP. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol. 2009; 4(4): 838–44.

McEwan P, Bennett Wilton H, Ong ACM, Ørskov B, Sandford R, Scolari F, et al. A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): The ADPKD Outcomes Model. BMC Nephrol. 2018; 19(1): 1–12.

Wang X, Yang X, Zhong X, Wang Z, Xue S, Yu W, et al. Percutaneous Nephrolithotomy under Ultrasound Guidance in Patients with Renal Calculi and Autosomal Dominant Polycystic Kidney Disease: A Report of 11 Cases. Adv Urol. 2017.

Zhang J, Zhang J, Xing N. Polycystic kidney disease with renal calculi treated by percutaneous nephrolithotomy: A report of 11 cases. Urol Int. 2014; 92(4): 427–32.

Abed A, El-Nahas A, M. Al-Kandari A, Shokeir A. Percutaneous Nephrolithotomy (PCNL) in the Treatment of Stones Within Horseshoe Kidneys and in Patients with Autosomal Dominant Polycystic Kidney Disease. In: Difficult Cases in Endourology. 2013. p. 115–21.

Singh V, Sinha RJ, Gupta DK. Percutaneous nephrolithotomy in autosomal dominant polycystic kidney disease: Is it different from percutaneous nephrolithotomy in normal kidney? Curr Urol. 2013; 7(1): 7–13.

Chapman, Guay-Woodford, Grantham, Torres, Bae, D.A. B, et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney. 2003; 64(3): 1035–45.

Schrier RW, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Friend K, Gitomer B, et al. Predictors of Autosomal Dominant Polycystic Kidney Disease Progression. J Am Soc Nephrol. 2014; 25(11): 2399–418.

Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University